Updated results from the four studies will be presented in Oral Reports or Posters at the ASCO Annual Meeting
The combined entity will enable us to better serve the needs of patients, healthcare professionals and our customers around the world
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Further strengthens BaseLaunch's global pharma industry partnerships
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Sanofi will leverage this partnership to provide access to proprietary data to develop AI models
Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD
The funds raised from the Whitathon run are utilized to treat underprivileged children suffering from Retinoblastoma
Subscribe To Our Newsletter & Stay Updated
